Staphylococcal Infections are caused by Staphylococcus bacteria, with Staphylococcus aureus being the primary pathogenic species. These bacteria commonly colonize the skin and mucous membranes, but under certain conditions, they can cause a range of infections. Skin infections, such as boils, impetigo, and cellulitis, are common manifestations of Staphylococcal Infections. More severe infections include pneumonia, osteomyelitis, and bacteremia. One significant concern in Staphylococcal Infections is the emergence of antibiotic-resistant strains, particularly methicillin-resistant Staphylococcus aureus (MRSA). MRSA infections pose challenges in clinical management, as these bacteria are resistant to multiple antibiotics, limiting treatment options. Prevention strategies involve proper wound care, hygiene practices, and the judicious use of antibiotics to minimize the development of resistant strains. Research in Staphylococcal Infections explores new treatment modalities, including novel antibiotics and alternative therapeutic approaches. The understanding of the molecular mechanisms underlying Antibiotic Resistance and virulence factors in Staphylococcus aureus informs the development of targeted therapies to improve outcomes in Staphylococcal Infections.